Newcastle University
This 4-year Prostate Cancer UK-funded project investigates how obesity-induced metabolic dysfunction-associated steatotic liver disease creates a permissive hepatic microenvironment for prostate cancer liver metastases and contributes to treatment resistance. The postholder will work across research groups to establish and analyse pre-clinical mouse models, using immunological, histological, and molecular approaches to define liver microenvironment remodeling during metastatic progression. The role aims to identify mechanisms that can be targeted to improve treatment responses in prostate cancer liver metastases.
Headquarters
Newcastle Upon Tyne, England, United Kingdom
Company Size
10001+ employees
Discover Newcastle University, one of the UK’s top rated research universities and a founding member of the Russell group, located in a vibrant and inclusive student city.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Newcastle University.
24% below the average for this role
Research Scientist
NationalunP2
Computational Postdoctoral Scientist – Spatial and Single-Cell Cancer Genomics
oraclecloudinfrastructure
Computational Postdoctoral Scientist – Spatial and Single-Cell Cancer Genomics
Oracle
Computational Postdoctoral Scientist – Spatial and Single-Cell Cancer Genomics
Oracle
Computational Postdoctoral Scientist – Spatial and Single-Cell Cancer Genomics
Oracle
Postdoctoral Fellow - Wen-Xing Ding Lab
University of Kansas Medical Center